<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04191174</url>
  </required_header>
  <id_info>
    <org_study_id>FIRH_Xe004</org_study_id>
    <nct_id>NCT04191174</nct_id>
  </id_info>
  <brief_title>Ventilation Heterogeneity Prior to Lung Resection</brief_title>
  <official_title>Prevalence and Clinical Relevance of Ventilation Heterogeneity and Luminal Cellular Inflammation in Lung Cancer Patients Prior to Lung Resection</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>McMaster University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Cyclomedica Australia Pty Ltd</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Ontario Lung Association</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>St. Joseph's Healthcare Hamilton</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>McMaster University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a single centre prospective six-week observational study to understand the prevalence
      and clinical relevance of abnormal ventilation of the lung (assessed by Technegas ventilation
      single photon emission computed tomography (V SPECT) and hyperpolarized 129Xe magnetic
      resonance imaging (MRI)), in the presence or absence of airway inflammation (assessed by
      sputum cell counts), in lung cancer patients prior to lung resection surgery.
    </textblock>
  </brief_summary>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date type="Actual">January 6, 2020</start_date>
  <completion_date type="Anticipated">July 1, 2021</completion_date>
  <primary_completion_date type="Anticipated">July 1, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Abnormal ventilation heterogeneity assessed by Technegas V SPECT</measure>
    <time_frame>Baseline</time_frame>
    <description>Proportion of patients with abnormal ventilation heterogeneity, assessed by Technegas V SPECT, prior to lung resection for lung cancer.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Abnormal ventilation heterogeneity assessed by 129Xe MRI</measure>
    <time_frame>Baseline</time_frame>
    <description>Proportion of patients with abnormal ventilation heterogeneity, assessed by 129Xe MRI, prior to lung resection for lung cancer.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Technegas V SPECT ventilation heterogeneity and luminal cellular inflammation</measure>
    <time_frame>Baseline</time_frame>
    <description>Proportion of patients with preoperative luminal cellular inflammation in the preoperative ventilation heterogeneity normal and abnormal groups, assessed by Technegas V SPECT.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>129Xe MRI ventilation heterogeneity and luminal cellular inflammation</measure>
    <time_frame>Baseline</time_frame>
    <description>Proportion of patients with preoperative luminal cellular inflammation in the preoperative ventilation heterogeneity normal and abnormal groups, assessed by 129Xe MRI.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of post-operative pulmonary complications (PPC): Technegas V SPECT ventilation heterogeneity</measure>
    <time_frame>up to 4 weeks</time_frame>
    <description>Difference in incidence of PPC and related impact measures in preoperative ventilation heterogeneity normal and abnormal patients, assessed by Technegas V SPECT</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of PPC: 129Xe MRI ventilation heterogeneity</measure>
    <time_frame>up to 4 weeks</time_frame>
    <description>Difference in incidence of PPC and related impact measures in preoperative ventilation heterogeneity normal and abnormal patients, assessed by 129Xe MRI.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of PPC: Technegas V SPECT ventilation heterogeneity and luminal cellular inflammation</measure>
    <time_frame>up to 4 weeks</time_frame>
    <description>Difference in incidence of PPC and related impact measures in preoperative ventilation heterogeneity abnormal patients, assessed by Technegas V SPECT, with and without preoperative luminal cellular inflammation.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of PPC: 129Xe MRI ventilation heterogeneity and luminal cellular inflammation</measure>
    <time_frame>up to 4 weeks</time_frame>
    <description>Difference in incidence of PPC and related impact measures in preoperative ventilation heterogeneity abnormal patients, assessed by 129Xe MRI, with and without preoperative luminal cellular inflammation.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Correlation between ventilation heterogeneity quantified by Technegas V SPECT and 129Xe MRI</measure>
    <time_frame>Baseline</time_frame>
    <description>Univariate correlation between preoperative ventilation heterogeneity quantified by Technegas V SPECT and 129Xe MRI.</description>
  </other_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">115</enrollment>
  <condition>Lung Cancer</condition>
  <arm_group>
    <arm_group_label>Adults undergoing lung resection for lung cancer</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Hyperpolarized 129Xe MRI</intervention_name>
    <description>Hyperpolarized 129Xe MRI to evaluate ventilation heterogeneity</description>
    <arm_group_label>Adults undergoing lung resection for lung cancer</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Technegas V SPECT</intervention_name>
    <description>Technegas V SPECT to evaluate ventilation heterogeneity</description>
    <arm_group_label>Adults undergoing lung resection for lung cancer</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Sputum Induction</intervention_name>
    <description>Sputum induction to evaluate luminal cellular inflammation</description>
    <arm_group_label>Adults undergoing lung resection for lung cancer</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Adults undergoing lung resection (at St. Joseph's Healthcare Hamilton) for lung cancer as
        part of their clinical care
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Undergoing lung resection for lung cancer at St. Joseph's Healthcare (Hamilton,
             Ontario) in accordance with British Thoracic Society guidelines.

          -  Males and females â‰¥ 18 years of age.

          -  Able and willing to provide written informed consent.

          -  Able and willing to comply with the study protocol.

        Exclusion Criteria:

          -  Previous lung resection surgery.

          -  Previous chest radiation.

          -  Patient has an implanted mechanically, electrically or magnetically activated device
             or any metal in their body which cannot be removed, including but not limited to
             pacemakers, neurostimulators, biostimulators, implanted insulin pumps, aneurysm clips,
             bioprosthesis, artificial limb, metallic fragment or foreign body, shunt, surgical
             staples.

          -  In the investigator's opinion, subject suffers from any physical, psychological or
             other condition(s) that might prevent performance of the MRI, such as severe
             claustrophobia.

          -  Pregnancy.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Parameswaran Nair, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>McMaster University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Firestone Institute for Respiratory Health, Research - St. Joseph's Healthcare</name>
      <address>
        <city>Hamilton</city>
        <state>Ontario</state>
        <zip>L8N 4A6</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <reference>
    <citation>Agostini P, Cieslik H, Rathinam S, Bishay E, Kalkat MS, Rajesh PB, Steyn RS, Singh S, Naidu B. Postoperative pulmonary complications following thoracic surgery: are there any modifiable risk factors? Thorax. 2010 Sep;65(9):815-8. doi: 10.1136/thx.2009.123083.</citation>
    <PMID>20805178</PMID>
  </reference>
  <reference>
    <citation>Lugg ST, Agostini PJ, Tikka T, Kerr A, Adams K, Bishay E, Kalkat MS, Steyn RS, Rajesh PB, Thickett DR, Naidu B. Long-term impact of developing a postoperative pulmonary complication after lung surgery. Thorax. 2016 Feb;71(2):171-6. doi: 10.1136/thoraxjnl-2015-207697.</citation>
    <PMID>26769017</PMID>
  </reference>
  <reference>
    <citation>Pike D, Kirby M, Guo F, McCormack DG, Parraga G. Ventilation heterogeneity in ex-smokers without airflow limitation. Acad Radiol. 2015 Aug;22(8):1068-78. doi: 10.1016/j.acra.2015.04.006. Epub 2015 May 23.</citation>
    <PMID>26008133</PMID>
  </reference>
  <reference>
    <citation>Sheikh K, Paulin GA, Svenningsen S, Kirby M, Paterson NA, McCormack DG, Parraga G. Pulmonary ventilation defects in older never-smokers. J Appl Physiol (1985). 2014 Aug 1;117(3):297-306. doi: 10.1152/japplphysiol.00046.2014. Epub 2014 Jun 5.</citation>
    <PMID>24903918</PMID>
  </reference>
  <reference>
    <citation>Bajc M, Chen Y, Wang J, Li XY, Shen WM, Wang CZ, Huang H, Lindqvist A, He XY. Identifying the heterogeneity of COPD by V/P SPECT: a new tool for improving the diagnosis of parenchymal defects and grading the severity of small airways disease. Int J Chron Obstruct Pulmon Dis. 2017 May 26;12:1579-1587. doi: 10.2147/COPD.S131847. eCollection 2017.</citation>
    <PMID>28603413</PMID>
  </reference>
  <verification_date>January 2020</verification_date>
  <study_first_submitted>December 3, 2019</study_first_submitted>
  <study_first_submitted_qc>December 5, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">December 9, 2019</study_first_posted>
  <last_update_submitted>February 19, 2020</last_update_submitted>
  <last_update_submitted_qc>February 19, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 21, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>lung cancer</keyword>
  <keyword>lung resection</keyword>
  <keyword>ventilation heterogeneity</keyword>
  <keyword>Technegas V SPECT</keyword>
  <keyword>hyperpolarized 129Xe MRI</keyword>
  <keyword>airway inflammation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

